Spinal administration of DPP4 inhibitor IPI significantly decreased the hyperalgesia provoked by the intraplantar injection of carrageenan or partial nerve ligation, which could be eliminated by general opioid antagonist NTX and the selective MOR antagonist CTAP in inflammation but not neuropathy [33]. The gene discussed is DPP4; the disease is neuropathy.